These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33892849)

  • 81. Current Therapeutic Approaches in Leukodystrophies: A Review.
    Gordon-Lipkin E; Fatemi A
    J Child Neurol; 2018 Nov; 33(13):861-868. PubMed ID: 30112967
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Diffusion and ADC-map images detect ongoing demyelination on subcortical white matter in an adult metachromatic leukodystrophy patient with autoimmune Hashimoto thyroiditis.
    Miura A; Kumabe Y; Kimura E; Yamashita S; Ueda A; Hirano T; Uchino M
    BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22798296
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Adult Leukodystrophies: A Step-by-Step Diagnostic Approach.
    Resende LL; de Paiva ARB; Kok F; da Costa Leite C; Lucato LT
    Radiographics; 2019; 39(1):153-168. PubMed ID: 30620693
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Consensus statement on preventive and symptomatic care of leukodystrophy patients.
    Van Haren K; Bonkowsky JL; Bernard G; Murphy JL; Pizzino A; Helman G; Suhr D; Waggoner J; Hobson D; Vanderver A; Patterson MC;
    Mol Genet Metab; 2015 Apr; 114(4):516-26. PubMed ID: 25577286
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Leukodystrophies and genetic leukoencephalopathies in children.
    Sarret C
    Rev Neurol (Paris); 2020; 176(1-2):10-19. PubMed ID: 31174885
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Glial cells in the driver seat of leukodystrophy pathogenesis.
    Garcia LM; Hacker JL; Sase S; Adang L; Almad A
    Neurobiol Dis; 2020 Dec; 146():105087. PubMed ID: 32977022
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proceedings of the Leukodystrophies Symposium of the Child Neurology Society Annual Meeting. Washington, DC, USA. October 9, 2002.
    J Child Neurol; 2003 Sep; 18(9):577-660. PubMed ID: 14640087
    [No Abstract]   [Full Text] [Related]  

  • 88. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
    Barrette B; Nave KA; Edgar JM
    Biol Chem; 2013 Dec; 394(12):1571-81. PubMed ID: 23959664
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gene-Based Approaches to Inherited Neurometabolic Diseases.
    Poletti V; Biffi A
    Hum Gene Ther; 2019 Oct; 30(10):1222-1235. PubMed ID: 31397176
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [MRI in the diagnosis of congenital white matter diseases and other neurodegenerative diseases].
    Bekiesińska-Figatowska M; Walecki J; Wagiel K; Jurkiewicz E
    Neurol Neurochir Pol; 2001; 35(4):605-19. PubMed ID: 11783404
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gene therapy in metachromatic leukodystrophy.
    Sevin C; Cartier-Lacave N; Aubourg P
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Metachromatic leukodystrophy--an update.
    Gieselmann V; Krägeloh-Mann I
    Neuropediatrics; 2010 Feb; 41(1):1-6. PubMed ID: 20571983
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
    Gieselmann V
    Acta Paediatr; 2008 Apr; 97(457):15-21. PubMed ID: 18339182
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Update on genetic disorders affecting white matter.
    Kaye EM
    Pediatr Neurol; 2001 Jan; 24(1):11-24. PubMed ID: 11182276
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Targeted leukodystrophy diagnosis based on charges and yields for testing.
    Richards J; Korgenski EK; Taft RJ; Vanderver A; Bonkowsky JL
    Am J Med Genet A; 2015 Nov; 167A(11):2541-3. PubMed ID: 26183797
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Long-term neuroimaging follow-up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoietic stem cell transplantation: evidence of myelin recovery and ongoing brain maturation.
    Ding XQ; Bley A; Kohlschütter A; Fiehler J; Lanfermann H
    Am J Med Genet A; 2012 Jan; 158A(1):257-60. PubMed ID: 22140054
    [No Abstract]   [Full Text] [Related]  

  • 97. Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair.
    Lotun A; Gessler DJ; Gao G
    Front Cell Neurosci; 2021; 15():661928. PubMed ID: 33967698
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Novel and known morbidities of leukodystrophies identified using a phenome-wide association study.
    Bonkowsky JL; Wilkes J; Ying J; Wei WQ
    Neurol Clin Pract; 2020 Oct; 10(5):406-414. PubMed ID: 33299668
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia.
    Sirkis DW; Bonham LW; Yokoyama JS
    Appl Clin Genet; 2021; 14():195-207. PubMed ID: 33833548
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Leukodystrophies: Five new things.
    van der Knaap MS; Wolf NI; Heine VM
    Neurol Clin Pract; 2016 Dec; 6(6):506-514. PubMed ID: 29849248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.